Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to test if there is
bioequivalence between the insulin aspart 100 U/mL (U100) formulation and the new insulin
aspart 200 U/mL (U200) formulation.